Earlier studies have shown that p53 activated by nutlin-3 treatment powerfully decreases the expression of M2-associated genes [35], resulting in the suppression of M2-like tumor-associated macrophages (TAMs) [36, 37]. The gene discussed is TP53; the disease is neoplasm.